MTOR and metabolic dysfunction-associated steatotic liver disease: This study investigated the effects of Rg5 on the phenotype of NAFLD induced by HFD in mice, including its key role in inhibiting the development of non-alcoholic fatty liver through the LKB1/AMPK/mTOR signaling pathway and the gut–microbiota–liver axis.